BioNTech SE ADR rises Monday, outperforms market

This post was originally published on this site

© Terrence Horan

COMPANY CLOSE UPDATES

The BioNTech SE ADR BNTX rose 8.48% to $108.90 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.66% to 3,799.61 and Dow Jones Industrial Average DJIA falling 0.29% to 31,008.69. This was the ADR’s sixth consecutive day of gains. BioNTech SE ADR closed $22.10 short of its 52-week high ($131.00), which the company achieved on December 11th.

Video: There’s no reason for the bull market to sustain its run right now: Strategist (CNBC)

There’s no reason for the bull market to sustain its run right now: Strategist
What to watch next

The ADR outperformed some of its competitors Monday, as AbbVie Inc. ABBV rose 1.63% to $109.02 and Amgen Inc. AMGN fell 0.39% to $237.57. Trading volume (4.8 M) eclipsed its 50-day average volume of 4.5 M.

Editor’s Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

Continue Reading